Navigation Links
Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks
Date:10/21/2008

A new test has been developed to measure the effectiveness of Aspirin Therapy, based on research showing that up to 25% of patients are not experiencing the benefits of taking aspirin on a daily basis. The Aspirin Response Test gives the physician an opportunity to alter treatment methods for the patient, resulting in further prevention of heart attacks.

Los Angeles (PRWEB) October 21, 2008 -- Millions of Americans are taking aspirin to help prevent heart attacks and strokes. But what is not generally known is that up to 25% of patients on aspirin therapy receive little or no benefit from it. And because aspirin can cause stomach upset, ulcers, and even gastrointestinal bleeding, this question has become a significant medical concern. Now, breakthrough research may have an answer, according to Dr. Joseph Sciabbarrasi, an integrative medical doctor practicing in West Los Angeles. "We now have a simple urine test to determine if aspirin is actually helping prevent blood clots from forming."

The new Aspirin Response Test (ART) measures a substance, thromboxane B2 which is associated with the formation of blood clots. Aspirin is supposed to reduce the formation of this substance in the body. "We know that aspirin is working when thromboxane B2 levels are very low," says Dr. Sciabbarrasi. "If they are not, a physician can look for ways to reduce risk factors such as high cholesterol or blood sugar. It may be necessary to change the dose of aspirin or consider another medication as well."

The test performed by Spectracell Laboratories in Houston, was prompted by research which showed that people who do not respond to aspirin are three times more likely to have a fatal heart attack or stroke.

"It's a new, cutting edge clinical tool to help guide physicians and patients to what is working and what is not," Sciabbarrasi says. "It individualizes therapy and helps us better treat our patients who take aspirin."

"I had a heart attack last April," says Robert, a 52-year-old manager of a car dealership in Los Angeles and placed on aspirin therapy by his cardiologist. He had the ART done in July. Both he and his cardiologist were grateful.

"The aspirin was not protecting me from another clot," he explained. "My cardiologist was surprised and increased my dose. Thank goodness - the next test was in a good range."

For additional information on the Aspirin Response Test, contact Joy Ichikawa or visit www.holisticdoctorlosangeles.com.

About Dr. Sciabbarrasi:
Dr. Sciabbarrasi offers cutting edge holistic and integrative medical care in a caring and supportive environment. His practice integrates conventional and complementary therapies including bioidentical hormone replacement therapy, cardiovascular health programs, immune system strengthening and intracellular nutrient and antioxidant analysis. His goal is to help individuals attain optimal health, often while undergoing conventional care. Dr. Sciabbarrasi's office is located at 2001 S. Barrington Ave, Suite 208, Los Angeles, CA 90025.

Contact:
Joy Ichikawa, Patient Relations Director
Integrative Medicine, Joseph Sciabbarrasi, MD
310-268-8466
http://holisticdoctorlosangeles.com

###

Read the full story at http://www.prweb.com/releases/aspirin_therapy/prevent_heart_attacks/prweb1495724.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Breakthrough Baldness Genetic Test
2. Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging
3. Swiss Institute of Bioinformatics announces major breakthrough
4. A breakthrough in contrast-enhanced intraoperative ultrasonography
5. A new breakthrough in timing of urgent endoscopy for gastrointestinal bleeding patients
6. Dental Convention to Highlight Latest Breakthroughs in Dentistry
7. New discovery about growth factor can be breakthrough for cancer research
8. Sigma Breakthrough Technologies, Inc. (SBTI) Is Expanding Its Service Offering for Global Clients by Announcing the Public Listing of SBTI Europe GmbH
9. Presidential medal for technological breakthroughs earned by 2 chemical engineering professors
10. CytoViva(R) Introduces Breakthrough Nano-Technology Research Tool
11. Wellcorps International Releases Breakthrough Multi-Benefit WellCapAM(TM) Activation Complex
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks 
(Date:3/29/2017)... ... 29, 2017 , ... In the United States alone, up to 36% of ... types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors are ... more effective treatment options, the San Diego Gamma Knife Center offers a ...
(Date:3/29/2017)... , ... March 30, 2017 , ... Grass pollen is the main cause of hay ... the stuff. The season for grass pollen runs from May to July each year; with ... fever victim to do? HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an effective defense ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy ... "Wonder Spice", it has been used for thousands of years. , "The West has ... author of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and ... two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy drink, ...
(Date:3/29/2017)... ... March 29, 2017 , ... Patients interested in receiving ... from Dr. Jamie Cameron, with or without a referral. The FASTBRACES system is ... Depending on each patient’s case, treatment with the FASTBRACES system could be completed ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... 2017 The new research portal ... comprehensive collection of company reports on UnitedHealth Group ... of their activities in the healthcare industry. ...      ... is going through a fundamental transformation globally-a shift from ...
(Date:3/30/2017)... Julie & Lefkowitz LLP, a class action law firm dedicated ... fiduciary duty claim involving the board of directors of Synergy ... If you are a shareholder of Synergy Pharmaceuticals and are ... charge, please visit us at: ... http://pjlfirm.com/synergy-pharmaceuticals-inc/ ...
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets has ... report to their offering. ... The global gas chromatograph market to grow at ... The report, Global Gas Chromatograph Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology: